1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

      1 ,
      The Journal of urology
      Ovid Technologies (Wolters Kluwer Health)

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Of all medical disciplines it is exclusively in urology in which immunotherapy for cancer has an established position today with intravesical bacillus Calmette-Guerin (BCG) against superficial bladder carcinoma recurrences. BCG is regarded as the most successful immunotherapy to date. However, the mode of action has not yet been fully elucidated. We provide a thorough overview of this complex field of research.

          Related collections

          Author and article information

          Journal
          J. Urol.
          The Journal of urology
          Ovid Technologies (Wolters Kluwer Health)
          0022-5347
          0022-5347
          Sep 2003
          : 170
          : 3
          Affiliations
          [1 ] Department of Urology, HELIOS Agnes Karll Hospital, Am Hochkamp 21, 23611 Bad Schwartau, Germany. aboehle@badschwartau.helios-kliniken.de
          Article
          S0022-5347(05)63288-0
          10.1097/01.ju.0000073852.24341.4a
          12913751
          7fe36fb2-c6ac-496c-9130-bd7830932c01

          Comments

          Comment on this article